Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC: BAYRY) to Buy from Neutral, while ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...

Gemini filed a confidential statement with the Securities & Exchange Commission (SEC) on Friday for an initial public ...

GPIX combines S&P 500 exposure with dynamic covered calls for income and downside support, but faces near-term pressure. Find ...

Investing.com -- Goldman Sachs has lowered its Tesla (NASDAQ: TSLA) vehicle delivery and EPS estimates, citing "weaker monthly datapoints in key regions" such as China, the US, and Europe, along with ...

The crypto exchange has been taking major steps to go public in the U.S., including hiring Goldman Sachs and Citigroup as its ...

BlackRock global chief investment officer of fixed income, Rick Rieder, says the country's debt position could end up ...

MasTec (NYSE:MTZ) +2.5% in Friday's trading as Goldman Sachs upgrades shares to Buy from Neutral with a $195 price target, ...

In a significant secondary market move, prominent investors like SBI Mutual Fund and Goldman Sachs acquired a 1.8% stake in ...

The bank’s CFO, general counsel and two other executives are also set to receive multimillion-dollar bonuses over “ongoing ...

Top crypto stocks like COIN, MSTR, and MARA faced declines of 4-5% amid liquidity shift to support Circle's stellar IPO debut ...